It is difficult to simultaneously achieve both moderate adhesion to the skin and strong adhesion to a wearable device, but a new polyurethane pressure-sensitive adhesive is providing a solution.
Wearable devices are used in medicine to continuously monitor signals such as electrocardiograms and electroencephalograms. They can also be used to monitor physical conditions during exercise. To improve the accuracy of the analysis, many studies have been conducted by directly attaching wearable devices to the skin using a pressure-sensitive adhesive (PSA) sheet.
The “COVID-19 smart patch” was developed for skin-friendly medical use and contains electrodes and conductive inks to register vital signs.
April 29, 2020
In collaboration with six medical and technology companies, Henkel has developed a smart health patch that allows continuous, remote, and wireless monitoring of patients’ heartbeat and respiration.
Avery Dennison reports that the site is designed for everyone from engineers to buyers in companies that manufacture pressure-sensitive products used in automotive, building and construction, electronics, general industrial, graphics and signage, labels and packaging, and medical applications.
April 28, 2020
Avery Dennison Performance Polymers has launched a more dynamic website with enhanced functionality and improved product selection and search features.
Adhesive manufacturers are developing new technologies that converters can present to their packaged goods customers and enable them to capture more market share.
Pressure-sensitive adhesives (PSAs) continue to gain traction in the broad category of packaging. PSAs are rapidly changing the way goods are packaged and delivered to consumers in traditional retail and via ecommerce.
Called poly(catechol-styrene), the adhesive was engineered to mimic the glue that mussels naturally use to attach to substrates in the ocean.
March 26, 2020
Mussel Polymers Inc. (MPI), a startup created by technology development company Wardenclyffe Chemicals Inc., has licensed patented underwater adhesive technology from the Purdue Research Foundation.
3M will retain its transdermal drug delivery components business.
December 23, 2019
3M recently announced that it has entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, LLC.